Sören Lehmann

Pathway activation model for personalized prediction of drug synergy

Trac, Quang Thinh; Huang, Yue; Erkers, Tom; Östling, Päivi et al.

Ingår i eLIFE, 2025

• DOI för Pathway activation model for personalized prediction of drug synergy
• Ladda ner fulltext (pdf) av Pathway activation model for personalized prediction of drug synergy

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Sobas, Marta Anna; Turki, Amin T.; Ramiro, Angela Villaverde; Hernandez-Sanchez, Alberto et al.

Ingår i Haematologica, s. 1126-1140, 2025

• DOI för Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
• Ladda ner fulltext (pdf) av Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Voso, Maria Teresa; Guarnera, Luca; Lehmann, Sören; Doehner, Konstanze et al.

Ingår i Blood, s. 234-243, 2025

• DOI för Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

Miliara, Sophia; Cozzi, Elisabetta; Zhong, Xiangfu; Chan, Isaac et al.

Ingår i Leukemia, s. 663-666, 2024

• DOI för The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia
• Ladda ner fulltext (pdf) av The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery

Ramos, Anderson Daniel; Liang, Ying Yu; Surova, Olga; Bacanu, Smaranda et al.

Ingår i Cell Reports, 2024

• DOI för Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
• Ladda ner fulltext (pdf) av Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery

Pathway activation model for personalized prediction of drug synergy

Trac, Quang Thinh; Huang, Yue; Erkers, Tom; Östling, Päivi et al.

Ingår i eLIFE, 2025

• DOI för Pathway activation model for personalized prediction of drug synergy
• Ladda ner fulltext (pdf) av Pathway activation model for personalized prediction of drug synergy

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Sobas, Marta Anna; Turki, Amin T.; Ramiro, Angela Villaverde; Hernandez-Sanchez, Alberto et al.

Ingår i Haematologica, s. 1126-1140, 2025

• DOI för Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance
• Ladda ner fulltext (pdf) av Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Voso, Maria Teresa; Guarnera, Luca; Lehmann, Sören; Doehner, Konstanze et al.

Ingår i Blood, s. 234-243, 2025

• DOI för Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

Miliara, Sophia; Cozzi, Elisabetta; Zhong, Xiangfu; Chan, Isaac et al.

Ingår i Leukemia, s. 663-666, 2024

• DOI för The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia
• Ladda ner fulltext (pdf) av The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia

Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery

Ramos, Anderson Daniel; Liang, Ying Yu; Surova, Olga; Bacanu, Smaranda et al.

Ingår i Cell Reports, 2024

• DOI för Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
• Ladda ner fulltext (pdf) av Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery

Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Abé, Christoph; Keto, Jaana; Lilja, Mathias; Konradsen, Mie et al.

Ingår i Leukemia and Lymphoma, s. 1493-1501, 2024

• DOI för Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
• Ladda ner fulltext (pdf) av Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data

Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Struyf, Nona; Österroos, Albin; Vesterlund, Mattias; Arnroth, Cornelia et al.

Ingår i npj Precision Oncology, 2024

• DOI för Delineating functional and molecular impact of ex vivo sample handling in precision medicine
• Ladda ner fulltext (pdf) av Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective

Moreno Berggren, Daniel; Garelius, Hege; Willner Hjelm, Petter; Nilsson, Lars et al.

Ingår i Leukemia, s. 1103-1112, 2023

• DOI för Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective
• Ladda ner fulltext (pdf) av Therapy-related MDS dissected based on primary disease and treatment: a nationwide perspective

Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Dolinska, Monika; Cai, Huan; Mansson, Alma; Shen, Jingyi et al.

Ingår i Blood, s. 73-89, 2023

• DOI för Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
• Ladda ner fulltext (pdf) av Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option

Prediction model for drug response of acute myeloid leukemia patients

Trac, Quang Thinh; Pawitan, Yudi; Mou, Tian; Erkers, Tom et al.

Ingår i npj Precision Oncology, 2023

• DOI för Prediction model for drug response of acute myeloid leukemia patients
• Ladda ner fulltext (pdf) av Prediction model for drug response of acute myeloid leukemia patients

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Ingår i Haematologica, s. 1015-1025, 2023

• DOI för Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
• Ladda ner fulltext (pdf) av Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes

Ali, Muhammad; Giannakopoulou, Eirini; Li, Yingqian; Lehander, Madeleine et al.

Ingår i Nature Biotechnology, s. 488-498, 2022

• DOI för T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
• Ladda ner fulltext (pdf) av T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes

A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Österroos, Albin; Maia, Tania; Eriksson, Anna; Jädersten, Martin et al.

Ingår i Haematologica, s. 1528-1537, 2022

• DOI för A risk score based on real-world data to predict early death in acute promyelocytic leukemia
• Ladda ner fulltext (pdf) av A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial

Jadersten, Martin; Lilienthal, Ingrid; Tsesmetzis, Nikolaos; Lourda, Magda et al.

Ingår i Journal of Internal Medicine, s. 925-940, 2022

• DOI för Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial
• Ladda ner fulltext (pdf) av Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial

Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

Orsmark-Pietras, Christina; Landberg, Niklas; Lorenz, Fryderyk; Uggla, Bertil et al.

Ingår i Genes, Chromosomes and Cancer, s. 426-433, 2021

• DOI för Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
• Ladda ner fulltext (pdf) av Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia

Sanjiv, Kumar; Calderón-Montaño, José Manuel; Pham, Therese M.; Erkers, Tom et al.

Ingår i Cancer Research, s. 5733-5744, 2021

• DOI för MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia
• Ladda ner fulltext (pdf) av MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia

Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study

Moreno Berggren, Daniel; Kjellander, Matilda; Backlund, Ellen; Engvall, Marie et al.

Ingår i British Journal of Haematology, s. 474-483, 2021

• DOI för Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study
• Ladda ner fulltext (pdf) av Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study

Rosso, Aldana; Juliusson, Gunnar; Lorenz, Fryderyk; Lehmann, Sören et al.

Ingår i Leukemia and Lymphoma, s. 1973-1981, 2021

• DOI för Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study
• Ladda ner fulltext (pdf) av Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice?: A population-based study

The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia

Mou, Tian; Pawitan, Yudi; Stahl, Matthias; Vesterlund, Mattias et al.

Ingår i American Journal of Hematology, s. 580-588, 2021

• DOI för The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia
• Ladda ner fulltext (pdf) av The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia

Impact of treatment delay in acute myeloid leukemia revisited

Juliusson, Gunnar; Hagberg, Oskar; Lazarevic, Vladimir Lj; Lehmann, Sören et al.

Ingår i Blood Advances, s. 787-790, 2021

• DOI för Impact of treatment delay in acute myeloid leukemia revisited

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Mareschal, Sylvain; Palau, Anna; Lindberg, Johan; Ruminy, Philippe et al.

Ingår i Blood Advances, s. 1003-1016, 2021

• DOI för Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia

Anande, Govardhan; Deshpande, Nandan P.; Mareschal, Sylvain; Batcha, Aarif M. N. et al.

Ingår i Clinical Cancer Research, s. 3597-3607, 2020

• DOI för RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia

Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia

Österroos, Albin; Björklund, My; Eriksson, Anna; Lindberg, Johan et al.

Ingår i Blood Cancer Journal, 2020

• DOI för Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
• Ladda ner fulltext (pdf) av Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia

Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Österroos, Albin; Eriksson, Anna; Antunovic, Petar; Cammenga, Jörg et al.

Ingår i British Journal of Haematology, 2020

• DOI för Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy

Rudd, Sean G.; Tsesmetzis, Nikolaos; Sanjiv, Kumar; Paulin, Cynthia B.J. et al.

Ingår i EMBO Molecular Medicine, 2020

• DOI för Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy
• Ladda ner fulltext (pdf) av Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy

The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

Juliusson, Gunnar; Jädersten, Martin; Deneberg, Stefan; Lehmann, Sören et al.

Ingår i Blood Advances, s. 1094-1101, 2020

• DOI för The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting

AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding

Mujahed, Huthayfa; Miliara, Sophia; Neddermeyer, Anne H.; Bengtzen, Sofia et al.

Ingår i Blood, s. 339-352, 2020

• DOI för AML displays increased CTCF occupancy associated with aberrant gene expression and transcription factor binding

Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people

Juliusson, Gunnar; Höglund, Martin; Lehmann, Sören

Ingår i Haematologica, s. 249-251, 2020

• DOI för Hypo, Hyper, or Combo: new paradigm for treatment of acute myeloid leukemia in older people

Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor

Derolf, Åsa; Juliusson, Gunnar; Benson, Lina; Flöisand, Yngvar et al.

Ingår i British Journal of Haematology, s. 187-191, 2020

• DOI för Decreasing early mortality in acute myeloid leukaemia in Sweden 1997-2014: improving performance status is a major contributing factor

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Juliusson, Gunnar; Hagberg, Oskar; Lazarevic, Vladimir Lj; Ölander, Emma et al.

Ingår i Blood, s. 1558-1561, 2019

• DOI för Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Angenendt, Linus; Röllig, Christoph; Montesinos, Pau; Martinez-Cuadron, David et al.

Ingår i Journal of Clinical Oncology, s. 2632-2642, 2019

• DOI för Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts

Expression levels of long non-coding RNAs are prognostic for AML outcome

Mer, Arvind Singh; Lindberg, Johan; Nilsson, Christer; Klevebring, Daniel et al.

Ingår i Journal of Hematology & Oncology, 2018

• DOI för Expression levels of long non-coding RNAs are prognostic for AML outcome
• Ladda ner fulltext (pdf) av Expression levels of long non-coding RNAs are prognostic for AML outcome

Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register

Berggren, Daniel Moreno; Folkvaljon, Yasin; Engvall, Marie; Sundberg, Johan et al.

Ingår i British Journal of Haematology, s. 614-627, 2018

• DOI för Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register

Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia

Hornung, Roman; Jurinovic, Vindi; Batcha, Aarif M. N.; Bamopoulos, Stefanos A. et al.

Ingår i Scientific Reports, 2018

• DOI för Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
• Ladda ner fulltext (pdf) av Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia

Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis

Khalkar, Prajakta; Ali, Hani Abdulkadir; Codó, Paula; Argelich, Nuria Díaz et al.

Ingår i Free Radical Biology & Medicine, s. 247-257, 2018

• DOI för Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis
• Ladda ner fulltext (pdf) av Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis

Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia

Wang, Mei; Lindberg, Johan; Klevebring, Daniel; Nilsson, Christer et al.

Ingår i Journal of the National Cancer Institute, s. 1094-1101, 2018

• DOI för Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia
• Ladda ner fulltext (pdf) av Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia

CRISPR Screen Identifies MAD1L1, CDC27 and CDC42 as Determinants of Sensitivity to Sonic Hedgehog Inhibitor Sonidegib in Medulloblastoma Cell Lines

Rudd, S. G.; Paulin, C. B.; Nikolaos, T.; Sanjiv, K. et al.

Ingår i Pediatric Blood & Cancer, 2018

Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease

Tobiasson, Magnus; Abdulkadir, Hani; Lennartsson, Andreas; Katayama, Shintaro et al.

Ingår i Oncotarget, s. 28812-28825, 2017

• DOI för Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease
• Ladda ner fulltext (pdf) av Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease

Bone marrow stroma cells derived from mononuclear cells at diagnosis as a source of germline control DNA for determination of somatic mutations in acute myeloid leukemia

Mujahed, H.; Jansson, M.; Bengtzen, S.; Lehmann, Sören

Ingår i Blood Cancer Journal, 2017

• DOI för Bone marrow stroma cells derived from mononuclear cells at diagnosis as a source of germline control DNA for determination of somatic mutations in acute myeloid leukemia
• Ladda ner fulltext (pdf) av Bone marrow stroma cells derived from mononuclear cells at diagnosis as a source of germline control DNA for determination of somatic mutations in acute myeloid leukemia

Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells

Liu, Lisa L.; Beziat, Vivien; Oei, Vincent Y. S.; Pfefferle, Aline et al.

Ingår i CANCER IMMUNOLOGY RESEARCH, s. 654-665, 2017

• DOI för Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Juliusson, Gunnar; Abrahamsson, J; Lazarevic, V; Antunovic, P et al.

Ingår i Leukemia, s. 728-731, 2017

• DOI för Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Cancer specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemia

Qu, Ying; Siggens, Lee; Cordeddu, Lina; Gaidzik, Verena I et al.

Ingår i Blood, 2017

• DOI för Cancer specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemia

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Ilander, M; Olsson-Strömberg, Ulla; Schlums, H; Guilhot, J et al.

Ingår i Leukemia, s. 1108-1116, 2017

• DOI för Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
• Ladda ner fulltext (pdf) av Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

Lazarevic, Vladimir Lj; Rosso, Aldana; Juliusson, Gunnar; Antunovic, Petar et al.

Ingår i European Journal of Haematology, s. 493-500, 2017

• DOI för Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia: A population-based study from the Swedish AML registry

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013

Lehmann, Sören; Deneberg, S.; Antunovic, P.; Rangert-Derolf, A. et al.

Ingår i Leukemia, s. 1457-1459, 2017

• DOI för Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013

Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling

Wang, M.; Lindberg, J.; Klevebring, D.; Nilsson, C. et al.

Ingår i Leukemia, s. 2029-2036, 2017

• DOI för Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

Herold, Nikolas; Rudd, Sean G.; Ljungblad, Linda; Sanjiv, Kumar et al.

Ingår i Nature Medicine, s. 256-263, 2017

• DOI för Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

An open-label phase I dose-finding study of APR-246 in hematological malignancies

Deneberg, S.; Cherif, Honar; Lazarevic, V.; Andersson, P-O et al.

Ingår i Blood Cancer Journal, 2016

• DOI för An open-label phase I dose-finding study of APR-246 in hematological malignancies
• Ladda ner fulltext (pdf) av An open-label phase I dose-finding study of APR-246 in hematological malignancies

Anti-leukaemic effects induced by APR-246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells

Ali, Dina; Mohammad, Dara K.; Mujahed, Huthayfa; Jonson-Videsater, Kerstin et al.

Ingår i British Journal of Haematology, s. 117-126, 2016

• DOI för Anti-leukaemic effects induced by APR-246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells

Differential Dna Methylation In Cytogenetically Normal Acute Myeloid Leukemia Is Linked To Altered Gene Expression Of Enhancer Target Genes

Qu, Y.; Siggens, L.; Cordeddu, L.; Ekwall, K. et al.

Ingår i Haematologica, s. 209-210, 2016

Validation Of Prognostic Scoring Systems For Myelodysplastic Syndromes In The Swedish Mds-Register

Berggren, Daniel Moreno; Folkvaljon, Y.; Engvall, M.; Sundberg, J. et al.

Ingår i Haematologica, s. 243-243, 2016

Characterization and prognostic features of secondary acute myeloid leukemia (AML) in a population-based setting: A report from the Swedish Acute Leukemia Registry

Hulegårdh, Erik; Nilsson, Christer; Lazarevic, Vladimir; Garelius, Hege et al.

Ingår i American Journal of Hematology, s. 208-214, 2015

• DOI för Characterization and prognostic features of secondary acute myeloid leukemia (AML) in a population-based setting: A report from the Swedish Acute Leukemia Registry

Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

Lazarevic, Vladimir; Hörstedt, Ann-Sofi; Johansson, Bertil; Antunovic, Petar et al.

Ingår i European Journal of Haematology, s. 419-423, 2015

• DOI för Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia

Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis

Eriksson, Anna; Lennartsson, Andreas; Lehmann, Sören

Ingår i Experimental Hematology, s. 609-624, 2015

• DOI för Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis

Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia

Lazarevic, Vladimir; Rosso, Aldana; Juliusson, Gunnar; Antunovic, Petar et al.

Ingår i American Journal of Hematology, s. 800-805, 2015

• DOI för Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia

Mature, Adaptive-like CD56(DIM) NK Cells in Chronic Myeloid Leukemia Patients in Treatment Free Remission

Ilander, Mette; Schlums, Heinrich; Olsson-Strömberg, Ulla; Lahteenmaki, Hanna et al.

Ingår i Blood, 2015

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Juliusson, Gunnar; Lazarevic, Vladimir; Antunovic, Petar; Derolf, Asa Rangert et al.

Ingår i Blood, 2015

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Deneberg, Stefan; Lundin, Ebba; Lazarevic, Vladimir; Benson, Lina et al.

Ingår i Blood, 2015

Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes

Qu, Ying; Lennartsson, Andreas; Gaidzik, Verena I.; Deneberg, Stefan et al.

Ingår i Epigenetics, s. 1108-1119, 2014

• DOI för Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes

Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Genovese, Giulio; Kaehler, Anna K.; Handsaker, Robert E.; Lindberg, Johan et al.

Ingår i New England Journal of Medicine, s. 2477-2487, 2014

• DOI för Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Höglund, Martin; Sandin, Fredrik; Hellstrom, Karin; Bjoreman, Mats et al.

Ingår i Blood, s. 1284-1292, 2013

• DOI för Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Integrated multi-omic profiling of azacitidine-venetoclax in AML reveals additional targetable pathways to improve the treatment

Österroos, Albin; Zhong, Xiangfu; Gamboa Cedeno, Angelica; Junkunlo, Kingkamon et al.